Activity of paromomycin against Leishmania amazonensis: Direct correlation between susceptibility in vitro and the treatment outcome in vivo
Paromomycin is an aminoglycoside antibiotic approved in 2006 for the treatment of visceral leishmaniasis caused by Leishmania donovani in Southeast Asia. Although this drug is not approved for the treatment of visceral and cutaneous leishmaniasis in Brazil, it is urgent and necessary to evaluate the...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2020-12-01
|
| coleção: | International Journal for Parasitology: Drugs and Drug Resistance |
| Assuntos: | |
| Acesso em linha: | http://www.sciencedirect.com/science/article/pii/S221132072030021X |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|